Ignite Creation Date:
2025-12-24 @ 1:21 PM
Ignite Modification Date:
2025-12-31 @ 4:44 AM
Study NCT ID:
NCT04478695
Status:
TERMINATED
Last Update Posted:
2024-03-08
First Post:
2020-07-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of AMG 330 in Combination With Pembrolizumab in Adult With Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-09-29
Start Date Type:
ACTUAL
Primary Completion Date:
2020-10-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-10-23
Completion Date Type:
ACTUAL
First Submit Date:
2020-07-16
First Submit QC Date:
None
Study First Post Date:
2020-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-08-11
Results First Submit QC Date:
None
Results First Post Date:
2024-03-08
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-08-11
Last Update Post Date:
2024-03-08
Last Update Post Date Type:
ACTUAL